Theratechnologies rises on smaller-than-expected Q4 loss

Theratechnologies

21/02/2024 16:48

** U.S.-listed shares of Canadian drugmaker
Theratechnologies  THTX.O   TH.TO  rise 4.2% to $1.75  
    ** Company reports a net loss of 6 cents per share, smaller
than analysts' estimate of 24 cents per share 
    ** Reports Q4 revenue of $23.45 mln, versus analysts'
estimate of $23.36 mln - LSEG data  
    ** THTX posts R&D expenses of $5.23 mln in Q4, less than the
$9.46 mln a year ago, due to lower spending on developing its
experimental drugs
    ** As of Nov.30, the firm had cash, bonds and money market
funds of $40.39 mln 
    ** THTX forecasts 2024 revenue in the range of $87 mln to
$90 mln versus estimate of $91.35 mln 
    ** Stock has fallen 58.8% in the last 12 months 

 (Reporting by Sneha  S K)
 ((Sneha.SK@thomsonreuters.com;))